Prevalence of Diabetes and Cardiovascular Risk in the Middle East and Africa: Primary Results of the PACT-MEA Study

Figures

• 

  Figure.. Summary of primary findings in PACT-MEA. A, Type of atherosclerotic cardiovascular disease (ASCVD) among patients with established ASCVD (eASCVD; left) and type of coronary artery disease (CAD) among patients with eASCVD and CAD (right). Types of ASCVD and CAD are not mutually exclusive; 1 participant may have multiple diagnoses. Data are unweighted. B, Prevalence of eASCVD in people with type 2 diabetes (T2D), by country and overall (across the 7 countries). Prevalence estimates for each country are unweighted. Overall prevalence is calculated as a weighted estimate to account for the size of the diabetes population of each country. Diabetes prevalence data are from the IDF [International Diabetes Federation] Diabetes Atlas, 10th edition, 2021. C, Proportion of people within each ASCVD risk category according to European Society of Cardiology (ESC) 2021 guidelines, overall and by country. Overall risk category proportion (across the 7 countries) was calculated as a weighted estimate to account for the size of the diabetes population of each country. Individual country data are unweighted. There were 752 patients for whom data used to calculate the risk levels were missing; these…